Oncogenic Signaling Pathways in The Cancer Genome Atlas

Sanchez-Vega, Francisco, Mina, Marco, Armenia, Joshua, Chatila, Walid K., Luna, Augustin, La, Konnor C., Dimitriadoy, Sofia, Liu, David L. +771 more·2018·Cell

DOI 10.1016/j.cell.2018.03.035

Cited by (1,006)

Items 401–500 of 1,006

Proteogenomic insights suggest druggable pathways in endometrial carcinoma
Yongchao Dou, Lizabeth Katsnelson, Marina Gritsenko, Yingwei Hu, Boris A. Reva, Runyu Hong, Yi-Ting Wang, Iga Kołodziejczak, Rita Jui-Hsien Lu, Chia‐Feng Tsai et al. · 2023 · Cancer Cell
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework
Oleg N. Timofeev, Philippe Giron, Steffen Lawo, Martin Pichler, Amir Noeparast · 2024 · npj Precision Oncology
“Keaping” a lid on lung cancer: the Keap1-Nrf2 pathway
Sarah A. Best, Kate D. Sutherland · 2018 · Cell Cycle
A time-resolved multi-omic atlas of the developing mouse stomach
Xianju Li, Chunchao Zhang, Tongqing Gong, Xiaotian Ni, Jine Li, Dongdong Zhan, Mingwei Liu, Lei Song, Chen Ding, Jianming Xu et al. · 2018 · Nature Communications
A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies
Zhiwei Liu, Yingluo Liu, Lili Qian, Shangwen Jiang, Xiameng Gai, Shu Ye, Yuehong Chen, Xiaomin Wang, Linhui Zhai, Jun Qiang Xu et al. · 2021 · Molecular Cell
Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
Huaqiang Zhou, Yi Hu, Rongzhen Luo, Yuanyuan Zhao, Hui Pan, Liyan Ji, Ting Zhou, Lanjun Zhang, Hao Long, Fu J et al. · 2021 · Nature Communications
AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis
Yuhang Zhou, Jinglin Zhang, Hui Li, Tingting Huang, Chi Chun Wong, Feng Wu, Man Wu, Nuoqing Weng, Liping Liu, Alfred S.L. Cheng et al. · 2020 · Oncogene
The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer
Goutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani, Bastien Nguyen, Konrad Hermann Stopsack, Christoph K. Kreitzer, Sai Harisha Rajanala, Romina Ghale, Ying Zhang Mazzu, Nagavarakishore Pillarsetty et al. · 2022 · Clinical Cancer Research
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
Nicolás A. Giraldo, Esther N Drill, Baby Anusha Satravada, Imane El Dika, Angela Rose Brannon, Josephine Kam Tai K. Dermawan, Abhinita S. Mohanty, Kerem Özcan, Debyani Chakravarty, Ryma Benayed et al. · 2022 · Clinical Cancer Research
Chemoradiotherapy-induced ACKR2+ tumor cells drive CD8+ T cell senescence and cervical cancer recurrence
Dongfang Dai, Yifei Pei, Biqing Zhu, Deqiang Wang, Siyu Pei, Huan Huang, Qingchen Zhu, Xiuyu Deng, Jialin Ye, Jing Xu et al. · 2024 · Cell Reports Medicine
Chronic Inflammation and Cancer: Key Pathways and Targeted Therapies
Gauri Kapoor, Swati Prakash, V. P. Jaiswal, Ashok Kumar Singh · 2024 · Cancer Investigation
Personalized Cancer Models for Target Discovery and Precision Medicine
Carla Grandori, Christopher J. Kemp · 2018 · Trends in cancer
Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer
Wei Jiang, Meiju Ji · 2019 · Seminars in Cancer Biology
FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications
José Luis Marín‐Rubio, Laura Vela‐Martín, José Fernández‐Piqueras, María Villa‐Morales · 2019 · Cancers
Identification of hub genes and key pathways associated with the progression of gynecological cancer
Xi Zhang, Yudong Wang · 2019 · Oncology Letters
T‐cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment
Mei‐Chun Cai, Xiaojing Zhao, Min Cao, Pengfei Ma, Minjiang Chen, Jie Wu, Chenqiang Jia, Chunming He, Yujie Fu, Li Tan et al. · 2020 · The Journal of Pathology
NOTCH signalling in ovarian cancer angiogenesis
José Alejandro Pérez Fidalgo, Belén Ortega-Morillo, Soraya Simón, Eleftherios Pierre Samartzis, Stergios Boussios · 2020 · Annals of Translational Medicine
Substratum stiffness regulates Erk signaling dynamics through receptor-level control
Payam E. Farahani, Sandra B. Lemke, Elliot Dine, Giselle A. Uribe, Jared E. Toettcher, Celeste M. Nelson · 2021 · Cell Reports
Ceramide Kinase Inhibition Drives Ferroptosis and Sensitivity to Cisplatin in Mutant KRAS Lung Cancer by Dysregulating VDAC-Mediated Mitochondria Function
Ngoc Vu, Minjung Kim, Daniel Stephenson, H. Patrick MacKnight, Charles Edward Chalfant · 2022 · Molecular Cancer Research
YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis
ZhengMing Wu, Junhui Su, Fu-long Li, Tao Chen, Jaimie Mayner, Adam Jeffrey Engler, Shenghong Ma, Qingquan Li, Kun‐Liang Guan · 2023 · Nature Communications
CD147: an integral and potential molecule to abrogate hallmarks of cancer
Alphonce M. K. Nyalali, Angela U. Leonard, Yongxiang Xu, Huayu Li, Junlin Zhou, Xinrui Zhang, Tibera K. Rugambwa, Xiaohan Shi, Feng Li · 2023 · Frontiers in Oncology
Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy
Bicheng Ye, Aimin Jiang, Liang Feng, Changcheng Wang, Xiaoqing Liang, Pengpeng Zhang · 2024 · BioFactors
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy
Andrea Necchi, Gennady Bratslavsky, Robert John Corona, Jon Chung, Sherri Z. Millis, Julia Andrea Elvin, Jo‐Anne Vergilio, James H. Suh, Shakti H Ramkissoon, Eric Allan Severson et al. · 2018 · European Urology Focus
In silico drug repositioning: from large-scale transcriptome data to therapeutics
Ok‐Seon Kwon, Wankyu Kim, Hyuk‐Jin Cha, Haeseung Lee · 2019 · Archives of Pharmacal Research
OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine
Andrés López‐Cortés, César Paz‐y‐Miño, Santiago Xavier Guerrero, Alejandro Cabrera‐Andrade, Stephen J. Barigye, Cristian Robert Munteanu, Humberto González‐Díaz, Alejandro Pazos, Yunierkis Pérez‐Castillo, Eduardo Tejera · 2020 · Scientific Reports
Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T. van Geelen, Peter Stephen Savas, Zhi Ling Teo, Stephen James Luen, Chen-Fang Weng, Yi-An Ko, Keilly S. Kuykhoven, Franco Caramia, Roberto Salgado, Prudence A. Francis et al. · 2020 · Breast Cancer Research
Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study
Yu Imamura, Masayuki Watanabe, Eiji Oki, Masaru Morita, Hideo Baba · 2020 · Annals of Gastroenterological Surgery
Oncogene APOL1 promotes proliferation and inhibits apoptosis via activating NOTCH1 signaling pathway in pancreatic cancer
Jiewei Lin, Zhiwei Xu, Junjie Xie, Xiaxing Deng, Lingxi Jiang, Hao Chen, Chenghong Peng, Hongwei Li, Jiaqiang Zhang, Baiyong Shen · 2021 · Cell Death and Disease
Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets
Alexandros Karagiannakos, Maria Adamaki, Antonis Tsintarakis, Bořivoj Vojtěšek, Robin Fåhræus, Vassilis C. Zoumpourlis, Konstantinos Karakostis · 2022 · Cancers
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
Ying Jin, Hua Bao, Xiuning Le, Xiaojun Fan, Ming Tang, Xun Shi, Jun Zhao, Junrong Yan, Yang Xu, Kelly Quek et al. · 2019 · Oncogene
Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma
Yuyan Xu, Wei Liao, Qiong Luo, Dinghua Yang, Mingxin Pan · 2022 · Frontiers in Immunology
Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma
Xiaofei Song, Shiun Chang, Lucia Seminario‐Vidal, Álvaro de Mingo Pulido, Leticia Tordesillas, Xingzhi Song, Rhianna A. Reed, Andrea Harkins, Shannen Whiddon, Jonathan V. Nguyen et al. · 2022 · Cancer Discovery
Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology
Raghvendra Mall, Ratnakar R. Bynigeri, Rajendra Karki, R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti · 2022 · NAR Cancer
Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment
Wan‐Hsin Lin, Lisa M. Cooper, Panos Z. Anastasiadis · 2023 · Frontiers in Cell and Developmental Biology
Leveraging Public Single-Cell and Bulk Transcriptomic Datasets to Delineate MAIT Cell Roles and Phenotypic Characteristics in Human Malignancies
Tony Yao, Parisa Shooshtari, S. M. Mansour Haeryfar · 2020 · Frontiers in Immunology
Cryo-EM structure of a RAS/RAF recruitment complex
Park, Eunyoung, Rawson, Shaun, Schmoker, Anna, Kim, Byeong-Won, Oh, Sehee, Song, Kangkang, Jeon, Hyesung, Eck, Michael J. · 2023 · Nature Communications
The evolution of cyclin dependent kinase inhibitors in the treatment of cancer
Komal L. Jhaveri, Howard A. Burris, Timothy Anthony Yap, Erika Paige Hamilton, Hope S. Rugo, Jonathan Wade Goldman, Stephen G. Dann, Feng Liu, Gilbert Y. Wong, Heike I. Krupka et al. · 2021 · Expert Review of Anticancer Therapy
Splicing is an alternate oncogenic pathway activation mechanism in glioma
Robert Siddaway, Scott Milos, Arun Kumaran Anguraj Vadivel, Tara Dobson, Jyothishmathi Swaminathan, Scott T. Ryall, Sanja Pajovic, Palak G. Patel, Javad Nazarian, Oren Josh Becher et al. · 2022 · Nature Communications
Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease
Garth Powis, Emmanuelle J. Meuillet, Martín Indarte, Garrett Booher, Lynn Kirkpatrick · 2023 · Biomedicine & Pharmacotherapy
Cancer mutational burden is shaped by G4 DNA, replication stress and mitochondrial dysfunction
Albino Bacolla, Zu Ye, Zamal Ahmed, John A. Tainer · 2019 · Progress in Biophysics and Molecular Biology
A comprehensive overview of oncogenic pathways in human cancer
Feng Li, Tan Wu, Yanjun Xu, Qun Dong, Jing Xiao, Yingqi Xu, Qian Li, Chunlong Zhang, Jianxia Gao, Liqiu Liu et al. · 2019 · Briefings in Bioinformatics
Enhanced hexosamine metabolism drives metabolic and signaling networks involving hyaluronan production and O-GlcNAcylation to exacerbate breast cancer
Chatchadawalai Chokchaitaweesuk, Takashi Kobayashi, Tomomi Izumikawa, Naoki Itano · 2019 · Cell Death and Disease
Characteristics and Outcome of AKT1 E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry
Lillian Mary Smyth, Qin C Zhou, Bastien Nguyen, Celeste Yu, Eva M. Lepisto, Mónica Arnedos, Michael J. Hassett, Michele L. Lenoue-Newton, Natalie Blauvelt, Semih Doğan et al. · 2020 · Cancer Discovery
Detecting community in attributed networks by dynamically exploring node attributes and topological structure
Zhi-Hao Huang, Xiaoxiong Zhong, Qiang Wang, Maoguo Gong, Xiaoke Ma · 2020 · Knowledge-Based Systems
RETRACTED ARTICLE: ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation
Davide Esposito, Ila Pant, Yao Shen, Ruifang Qiao, Xiaobao Yang, Yiyang Bai, Jian Jun Jin, Poulikos I. Poulikakos, Stuart A. Aaronson · 2022 · Nature Communications · Retracted
MiR-142-3p targets HMGA2 and suppresses breast cancer malignancy
Behzad Mansoori, Pascal H. G. Duijf, Ali Mohammadi, Elham Safarzadeh, Henrik J. Ditzel, Morten F. Gjerstorff, William Chi Shing Cho, Behzad Baradaran · 2021 · Life Sciences
Understanding the complex pathogenesis of oral cancer: A comprehensive review
Maria Georgaki, Vasileios Ionas Theofilou, Efstathios Pettas, Eleana D. Stoufi, Rania H. Younis, Alexandros E. Kolokotronis, John J. Sauk, Nikolaos G. Nikitakis · 2021 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling
Jin-Fen Xiao, Andrew W. Caliri, Jason E. Duex, Dan Theodorescu · 2021 · Cancers
Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors
Xu Feng, Mengfan Tang, Merve Dede, Dan Su, Guangsheng Pei, Dadi Jiang, Chao Wang, Zhen Chen, Mi Li, Litong Nie et al. · 2022 · Science Advances
The role of tetraspanins pan-cancer
Runzhi Huang, Hanlin Sun, Ruoyi Lin, Jie Zhang, Huabin Yin, Shuyuan Xian, Man Li, Siqiao Wang, Zhenyu Li, Yannan Qiao et al. · 2022 · iScience
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
Andrew A. Davis, Jingqin Rosy Luo, Tiantian Zheng, Chao Dai, Xiaoxi Dong, Lu Tan, Rama Suresh, Foluso Olabisi Ademuyiwa, Caron E. Rigden, Timothy P. Rearden et al. · 2023 · Clinical Cancer Research
Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications
Britta Weigelt, Antonio Marra, Pier Selenica, Eric Rios‐Doria, Amir Momeni Boroujeni, Michael F. Berger, Kanika S. Arora, David Nemirovsky, Alexia E. Iasonos, Debyani Chakravarty et al. · 2023 · Cancer Discovery
Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
Liemei Lv, Xiangxiang Zhou · 2023 · MedComm
Cancer prognosis with shallow tumor RNA sequencing
Pedro Milanez‐Almeida, Andrew J. Martins, Ronald N. Germain, John S. Tsang · 2020 · Nature Medicine
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma
José Alberto Nakauma‐González, Maud Rijnders, Job van Riet, Michiel S. van der Heijden, Jens Voortman, Edwin P. J. G. Cuppen, Niven Mehra, Sandra van Wilpe, Sjoukje F. Oosting, L. Lucia Rijstenberg et al. · 2022 · European Urology
Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview
Eunus Sheemul Ali, Shamima Akter, Sarker Ramproshad, Banani Mondal, Thoufiqul Alam Riaz, Muhammad Torequl Islam, Ishaq Nasib Khan, Anca Oana Docea, Daniela Cornelia Călina, Javad Sharifi‐Rad et al. · 2022 · Cancer Cell International
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type
Abraham, Jim, Heimberger, Amy B., Marshall, John, Heath, Elisabeth, Drabick, Joseph, Helmstetter, Anthony, Xiu, Joanne, Magee, Daniel, Stafford, Phillip, Nabhan, Chadi et al. · 2021 · Translational Oncology
Tilting MYC toward cancer cell death
Colleen T. Harrington, Elena Sotillo, Chi Van Dang, Andrei Thomas‐Tikhonenko · 2021 · Trends in cancer
Autophagy and the Lysosomal System in Cancer
Suresh G. Kumar, Miguel Sánchez‐Álvarez, Fidel‐Nicolás Lolo, Flavia Trionfetti, Raffaele Strippoli, Marco Cordani · 2021 · Cells
Genomic and molecular features distinguish young adult cancer from later-onset cancer
William Lee, Zishan Wang, Miriam Saffern, Tomi Wei Jun, Kuan‐lin Huang · 2021 · Cell Reports
Multi-omics data integration approaches for precision oncology
Raidel Correa Aguila, Niuxia Alonso-Pupo, Erix W. Hernández‐Rodríguez · 2022 · Molecular Omics
The NRF2 antagonist ML385 inhibits PI3K‐mTOR signaling and growth of lung squamous cell carcinoma cells
Lili Ji, Nadeem Moghal, Xinru Zou, Yixuan Fang, Shuning Hu, Yuhui Wang, Ming‐Sound Tsao · 2022 · Cancer Medicine
Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance
Fabian Fröhlich, Luca Gerosa, Jeremy L. Muhlich, Peter Karl Sorger · 2023 · Molecular Systems Biology
Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalities
Liang Chang, Nancy Yoobin Jung, Adel Atari, Diego J. Rodriguez, Devishi Kesar, Tianyu Song, Matthew G. Rees, Melissa M. Ronan, Ruitong Li, Paloma A. Ruiz et al. · 2023 · Nature Genetics
Hippo Signaling at the Hallmarks of Cancer and Drug Resistance
Ramesh Kumar, Wanjin Hong · 2024 · Cells
An analysis of aging-related genes derived from the Genotype-Tissue Expression project (GTEx)
Kaiwen Jia, Chunmei Cui, Yuanxu Gao, Yuan Zhou, Qinghua Cui · 2018 · Cell Death Discovery
Scalable reinforcement-learning-based neural architecture search for cancer deep learning research
Prasanna Balaprakash, Romain Égelé, Misha Salim, Stefan M. Wild, Venkatram Vishwanath, Fangfang Xia, Tom Brettin, Rick Stevens · 2019 · International Conference for High Performance Computing, Networking, Storage and Analysis (SC)
Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
Karla Santos-de-Frutos, Carmen Segrelles, Corina Lorz · 2019 · Journal of Clinical Medicine
Stress Granules Involved in Formation, Progression and Metastasis of Cancer: A Scoping Review
Mohammad Reza Asadi, Dara Rahmanpour, Marziyeh Sadat Moslehian, Hani Sabaie, Mehdi Hassani, Soudeh Ghafouri‐Fard, Mohammad Naser Taheri, Maryam Rezazadeh · 2021 · Frontiers in Cell and Developmental Biology
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer
Harshabad Singh, Rachel Beth Keller, Kevin S. Kapner, Julien Dilly, Srivatsan Raghavan, Chen Yuan, Elizabeth F. Cohen, Michael Yevgeniy Tolstorukov, Elizabeth Andrews, Lauren K. Brais et al. · 2023 · Clinical Cancer Research
Notch and Wnt Dysregulation and Its Relevance for Breast Cancer and Tumor Initiation
Eike-Benjamin Braune, Anita Seshire, Urban Lendahl · 2018 · Biomedicines
YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia
Joshua Hatterschide, Paola A. Castagnino, Hee Won Kim, Steven M. Sperry, Kathleen T. Montone, Devraj Basu, Elizabeth A White · 2022 · eLife
Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
Yuqin Tang, Chengbin Guo, Yang Chun Zhao, Yumei Wang, Yongqiang Zhang, Dong Wang · 2022 · Frontiers in Immunology
Anticancer Potentials of the Lignan Magnolin: A Systematic Review
Md. Shimul Bhuia, Polrat Wilairatana, Raihan Chowdhury, Asraful Islam Rakib, Hossam Mohammed Kamli, Ahmad A. Shaikh, Henrique Douglas Melo Coutinho, Muhammad Torequl Islam · 2023 · Molecules
Entanglement of MAPK pathways with gene expression and its omnipresence in the etiology for cancer and neurodegenerative disorders
Joydeep Chakraborty, Sayan Chakraborty, Sohag Chakraborty, Mahesh Narayan · 2023 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
The Hippo pathway: Organ size control and beyond
Pengfei Guo, Sicheng Wan, Kun‐Liang Guan · 2024 · Pharmacological Reviews
Next-Generation Sequencing in Pancreatic Cancer
Gong-Qing Shen, Essa M. Aleassa, Richard Matthew Walsh, Gareth J Morris‐Stiff · 2019 · Pancreas
Long non-coding RNA in bladder cancer
Yuepeng Cao, Tian Tian, Weijian Li, Hanzi Xu, Chuanfei Zhan, Xuhong Wu, Chao Wang, Xiaoli Wu, Wanke Wu, Shuyun Zheng et al. · 2020 · Clinica Chimica Acta
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators
Jiakai Hou, Yunfei Wang, Leilei Shi, Yuan Chen, Chunyu Xu, Arash Saeedi, Ke Pan, Ritu Bohat, Nicholas A. Egan, Jodi A. McKenzie et al. · 2021 · Journal for ImmunoTherapy of Cancer
Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach
Zi-Yang Liu, An-Qiang Wang, Ying-Ying Pu, Zhong-Wu Li, Rui-Dong Xue, Chong Zhang, Xiao Xiang, J. E, Z. Bu, F. Bai et al. · 2021 · Oncogene
Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer
Nuria Camiña, T.M. Penning · 2021 · British Journal of Cancer
Systematic illumination of druggable genes in cancer genomes
Junjie Jiang, Jiao Yuan, Zhongyi Hu, Youyou Zhang, Tianli Zhang, Mu Xu, Meixiao Long, Yi Fan, Janos Laszlo Tanyi, Kathleen T. Montone et al. · 2022 · Cell Reports
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
Philip East, Gavin P. Kelly, Dhruva Biswas, Michela Marani, David C. Hancock, Todd H. Creasy, Kris F. Sachsenmeier, Charles Swanton, Julian Downward, Sophie de Carné Trécesson · 2022 · Nature Communications
Genomic Landscape and Clinical Utility in Korean Advanced Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program
Kyong Hwa Park, Jung Yoon Choi, Ah-Reum Lim, Ju Won Kim, Yoon Ji Choi, Soo Hyun Lee, Jae Sook Sung, Hee-Joon Chung, Byunghyun Jang, Dayoung Yoon et al. · 2021 · Cancer Discovery
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
Melissa Amy Lumish, Henry S. Walch, Steven Brad Maron, Walid Khaled Chatila, Yelena M. Kemel, Anna Maio, Geoffrey Yuyat Ku, David H. Ilson, Elizabeth Won, Jia Li et al. · 2023 · JNCI Journal of the National Cancer Institute
Gene regulatory networks in disease and ageing
Paula Unger Avila, Tsimafei Padvitski, Ana Carolina Leote, He Chen, Julio Sáez-Rodríguez, Martin Kann, Andreas Beyer · 2024 · Nature Reviews Nephrology
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
Enrique Rozengurt, Guido Eibl · 2026 · Signal Transduction and Targeted Therapy
Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule
Issan Zhang, Maja Beus, Ursula Stochaj, Phuong Uyen Le, Branka Zorc, Zrinka Rajić, Kevin Petrecca, Dušica Maysinger · 2018 · Cell Death Discovery
Long noncoding RNA VCAN‐AS1 contributes to the progression of gastric cancer via regulating p53 expression
Li Feng, Jian Li, Fan Li, Huanqin Li, Songhua Bei, Xiaohong Zhang, Zhen Yang · 2019 · Journal of Cellular Physiology
The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer
Nesrin M. Hasan, Nita Ahuja · 2019 · Cancers
GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression
Yuchen Jiang, Taiwen Li, Yi‐Ying Wu, Huanji Xu, Changqing Xie, Y. Dong, L. Zhong, Z Wang, Hang Zhao, Yong Zhou et al. · 2020 · Journal of Dental Research
NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer
Liam Baird, Masayuki P. Yamamoto · 2020 · Molecular and Cellular Biology
The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
Sarah Morice, Mathilde Mullard, Régis Brion, Maryne Dupuy, Sarah Renault, Robel A. Tesfaye, Bénédicte Brounais-Le Royer, Benjamin Ory, Françoise Rédiní, Franck Verrecchia · 2020 · Cancers
Deciphering the signaling network of breast cancer improves drug sensitivity prediction
Marco Tognetti, Attila Gábor, Mi Yang, Valentina Cappelletti, Jonas Windhager, Oscar M. Rueda, Konstantina Charmpi, Elham Esmaeilishirazifard, Alejandra Bruna, Natalie de Souza et al. · 2021 · Cell Systems
The interferon-inducible protein viperin controls cancer metabolic reprogramming to enhance cancer progression
Kyung Mi Choi, Jeong Jin Kim, Jihye Yoo, Ku Sul Kim, Youngeun Gu, John Eom, Haengdueng Jeong, Kyungeun Kim, Ki Taek Nam, Young Soo Park et al. · 2022 · Journal of Clinical Investigation
Targeting PP2A for cancer therapeutic modulation
Halle Ronk, Jared S. Rosenblum, Timothy Kung, Zhengping Zhuang · 2022 · Cancer Biology and Medicine
The KEAP1–NRF2 pathway regulates TFEB/TFE3-dependent lysosomal biogenesis
Athena Jessica S. Ong, Cerys E. Bladen, Tara A. Tigani, Anthony P. Karamalakis, Kimberley Jane Evason, Kristin Brown, Andrew Graham Cox · 2023 · Proceedings of the National Academy of Sciences
Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
Cai‐Jin Lin, Xi Jin, Ding Ma, Chao Chen, Yang Ou-Yang, Yu‐Chen Pei, Chaozheng Zhou, Feilin Qu, Yunjin Wang, Chenglin Liu et al. · 2024 · Cancer Cell
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic
Vikas Dembla, Neeta Somaiah, Pedro Coelho Barata, Kenneth R. Hess, Siqing Fu, Filip Jankú, Daniel D. Karp, Aung Naing, Sarina Anne Piha-Paul, Vivek Subbiah et al. · 2018 · Oncotarget
Mutational landscape of penile squamous cell carcinoma in a Chinese population
Yonghua Wang, Ke Wang, Yuanbin Chen, Juan Zhou, Ye Liang, Xuecheng Yang, Xiaoqi Li, Yanwei Cao, Dong Wang, Lei Luo et al. · 2019 · International Journal of Cancer